Previous 10 | Next 10 |
First drug approved for seborrheic dermatitis with a new mechanism of action in over two decades available in pharmacies this week Effective, safe, and very well-tolerated steroid-free foam provides rapid disease clearance and significant reduction in itch Seborrheic dermatitis affects mo...
New subgroup analysis from STRATUM study shows that individuals with an inadequate response, contraindication, or intolerance to steroids were 3.5 times more likely to achieve IGA Success with ZORYVE foam than an identical vehicle ZORYVE foam provided rapid and significant improvement in qu...
Individual patient response data highlight 91.5% of individuals treated with roflumilast cream had a measurable improvement in Eczema Area and Severity Index (EASI) in just 4 weeks 85% achieved measurable improvement by Week 1 (the earliest timepoint measured) Data presented at the 2024 W...
2024-01-03 16:34:46 ET Gainers: iHeartMedia ( IHRT ) +10% . Arcutis Biotherapeutics ( ARQT ) +8% . Cipher Mining ( CIFR ) +7% . Pacira BioSciences ( PCRX ) +6% . Argo Blockchain ( ARBK ) +6% . Losers: Cal-Main...
2024-01-03 10:25:39 ET More on Arcutis Biotherapeutics Arcutis Biotherapeutics: Almost There, But Needs Some Fine-Tuning Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation...
2024-01-03 05:29:44 ET Related stock stories: SoFi Technologies: Rapid Growth Might Be Worth The Risk Masonite And PGT Innovations: Slamming The Door Following A Big And Expensive Deal SoFi Technologies: Time To Load Up Bloomin’ Brands appoints Dave Ge...
2024-01-02 16:55:53 ET Gainers: Bloomin' Brands ( BLMN ) +6% . Arcutis Biotherapeutics ( ARQT ) +6% . Stronghold Digital Mining ( SDIG ) +5% . Longboard Pharmaceuticals ( LBPH ) +4% . Guardant Health ( GH ) +3% . Losers: ...
2023-12-26 09:45:08 ET Coinbase Global Inc (COIN) COIN is trading UP for the last 5 days, and it at trading at $177.12 with volume of 3,974,731 and a one day change of $1.64 (0.93%). Coinbase Global Inc has a 52-week low of 32.58 and a 52-week high of $121.46. The business's 50-day ...
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is one today's most active stocks by volume. So far today, approximately 2.81M shares of Arcutis Biotherapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 3.34M shares. Arcutis Biotherapeutics, Inc., a biopharmaceutical c...
2023-12-18 10:39:54 ET More on Arcutis Biotherapeutics Arcutis Biotherapeutics: Almost There, But Needs Some Fine-Tuning Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation...
News, Short Squeeze, Breakout and More Instantly...
Arcutis Biotherapeutics Inc. Company Name:
ARQT Stock Symbol:
NASDAQ Market:
Arcutis Biotherapeutics Inc. Website:
Approximately 40% of the 9 million individuals in the United States with plaque psoriasis experience involvement of the scalp Once-daily ZORYVE foam significantly improved both scalp and body psoriasis in a Phase 2b and a pivotal Phase 3 trial Data also show rapid reduction in scalp itc...
WESTLAKE VILLAGE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will host a virtual Key Opinion Leader (KOL) event fea...
ZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly and significantly reduces itch, the most bothersome symptom of atopic dermatitis (AD) Once-daily cream is for use anywhere on the body for any duration...